2Yasue H,Yoshimura M.Localization and mechanism of secretion of B-type natriuretic peptide in comparision with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation,1994,90(1):195～203.
3Hysrad ME.Klinge R,Spurkland A,et al.Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure.Scand J Clin Lab Invest,2000,60(4):299～309.
4Friedl W,Mair J,Thomas S,et al. Relationship between natriuretic peptide and hemodynamics in patients with heart failure at rest and after ergometric exercise.ClinChimActa,1999,281(1-2):121～126.
5Alan S,Padma K,Richard M,et al. Rapid measurment of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med,2002,347:161～167.
6Waku S,Iida N.Significance of brain natriuretic peptide masurement as a diagnositc indicator of cardiac function.Methods Inf Med,2000,39(3):249～253.
7Redfield MM, Rodeheffer RJ,Jacobsen SJ, et al.Plasma brain natriuretic peptide concentration :impact of age and gender.J Am Coll Cardiol,2002,40(5):976～982.
8Jensen KT,Carstens J,Ivarsen P,et al. A new ,fast and reliable radioim munoassay of brain natriuretic peptide in human plasma .Reference values in healthy subjects and in patients with different diseases .Scand J Clin Lab Invest,1997,57:529～540.
9Cherico A,Del RyS,Gianmessi D,et al.Measurement of cardiac natriuretic hormones(atrial natriuretic peptide,brain natriuretic peptide,and related peptides) in clinical practice:the need for a new generation of immunoassay methods.Clin Chem,2000,46(10):1 529～1 534.
10Wieczorek SJ,Wu AH,Christenson R,et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventriculcar dysfunction and heart failure :a multicenter evaluation.Am Heart J,2002,144(5):834～839.
二级参考文献7
1[1]Cowie MR. BNP: soon to become a routine measure in the care of patients with heart failure? Heart, 2000; 83:617 ～ 618
2[2]Hobbs R. Can heart failure be diagnosed in primary care? Brain na triuretic peptide assays make it easier. BMJ, 2000; 321:188～ 189
3[5]Cohn JN, Tognoni G, Glazer RD, et al. Rationale and design of the valsartan heart failure trial: a large multinational trial to assess the ffects of valsartan, an angiotension- receptor blocker, on morbid ity and mortality in chronic congestive heart failure. J card Failure, 1999;5: 155～ 160
4[6]Darbar D, Davidson NC, Gillpesie N, et al. Diagnosic value ofB type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardial, 1996; 78: 284 ～ 287
5[7]Roberto L, Aldo PM, Serge M. What does the future hold for BNP in cardiology? Heart, 2001;86:601 ～ 602
6[2]McLean AS,Tang B,Nalos M,et al.Increased B-type natriuretic peptide(BNP)level is a strong predictor for cardiac dysfunction in intensive care unit patients[J].Anacsth Intensive Care,2003,31(1):21-27.
8[5]Sudoh T,Minamino N,Kangawa K,et al.Brain natriuretic peptide-32:N-terminal SIX amino acid extended form of brain natriuretic peptide identified in porcine brain[J].Biochem Biophys Res Commun,1988,155(2):726-32.
9[6]Matin-Grez M,Fleming JT,Steinhauaen M.Atrial natriuretic peptide causes pre-glomerular vaaodilatation and post-glomerular vasodilatation in rat kidney[J].Nature,1986,324(6096):473-476.
10[7]Atamshi K,Mulrow PJ,Franco-Saenz R.Effect of atrial peptide on aldostemne production[J].J Clin Invest,1985,76(5):1807-1811.
